Peptide Synthesis Market Report and Forecast 2025-2034
Description
The global peptide synthesis market size was valued at USD 513.86 Million in 2024, driven by the increased emphasis on personalized medicine across the globe. The market size is anticipated to grow at a CAGR of 8.80% during the forecast period of 2025-2034 to achieve a value of USD 1194.36 Million by 2034.
Peptide Synthesis: Introduction
Peptide synthesis is a known laboratory technique which is used to generate peptides. Peptides are small chains of amino acids that are connected together with the peptide bonds. Peptides play a significant role in several fields, including medicine, biotechnology, and research. They can be used as therapeutic agents, diagnostic tools, or molecular probes for studying biological processes. In peptide synthesis, amino acids are put together in a unique sequence with the help of a step-by-step assembly technique to form the desired peptide. There are two primary methods of performing peptide synthesis: solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS).
Global Peptide Synthesis Market Analysis
The market for peptide synthesis is influenced by several trends, including the increased emphasis on peptide libraries and screening. The rising demand for long and difficult peptides is growing, including cyclic peptides, stapled peptides, and peptide conjugates. These peptides offer unique properties and enhanced stability, making them attractive for drug development and research applications.
Additionally, peptide-based therapeutics are continuously being explored for the treatment of rare genetic diseases as targeting specific peptides can potentially correct or modulate genetic defects. The development of peptide therapies for rare diseases is gaining momentum, which is driven by the advancements in gene editing technologies and personalized medicine approaches. Researchers are increasingly incorporating non-natural amino acids into peptide sequences to enhance their stability, bioactivity, and pharmacokinetic properties. This allows the development of peptide-based therapeutics with improved drug-like characteristics, expanding the potential applications of peptides in drug discovery and delivery. Outsourcing peptide synthesis to contract manufacturing organizations (CMOs) is becoming a popular trend among pharmaceutical and biotech companies, which is leading to higher peptide synthesis market demand. This trend allows companies to focus on their core competencies while accessing high-quality peptides for their drug development pipelines.
Automation and robotics are also being increasingly employed in peptide synthesis processes that enables high-throughput and efficient production. Automated peptide synthesizers and robotic systems facilitate precise control, rapid synthesis, and reduced human error, thereby enhancing the scalability and reproducibility of peptide manufacturing.
Global Peptide Synthesis Market Segmentations
Peptide Synthesis Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Technology
The market for peptide synthesis has been witnessing steady growth and is anticipated to witness significant growth in the coming years as well. The market growth is primarily driven by the increasing demand for therapeutics. Due to their exclusivity, potency, and low toxicity in comparison to traditional small molecule drugs, the demand for peptide-based therapeutics in regard with various diseases, such as cancer, diabetes, and cardiovascular disorders, is increasing and directly contributing to the global peptide synthesis market growth.
Additionally, the increasing number of ongoing advancements in peptide research, including understanding the structure-activity relationships and developing new synthesis techniques, are collectively contributing to the possibilities for the introduction of peptide-based therapeutics in the market with multiple benefits, propelling the demand for peptide synthesis technologies and services in the market.
The increasing emphasis on personalized medicine and targeted therapies has increased the demand for customized peptides in the market. Peptide synthesis enables the creation of peptides with unique sequences and modifications tailored to individual patient needs, leading to the development of personalized treatments. The rising availability of customisation as per the requirement is also contributing to the peptide synthesis market share. Peptides find applications in various fields, including biotechnology, life sciences, and diagnostics. Peptides are also used as tools for comprehending protein-protein interactions, as diagnostic biomarkers, and in the development of peptide-based vaccines. The expanding applications of peptides across these industries aid the growth of the peptide synthesis market.
Peptide Synthesis Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Peptide Synthesis: Introduction
Peptide synthesis is a known laboratory technique which is used to generate peptides. Peptides are small chains of amino acids that are connected together with the peptide bonds. Peptides play a significant role in several fields, including medicine, biotechnology, and research. They can be used as therapeutic agents, diagnostic tools, or molecular probes for studying biological processes. In peptide synthesis, amino acids are put together in a unique sequence with the help of a step-by-step assembly technique to form the desired peptide. There are two primary methods of performing peptide synthesis: solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS).
- Solid-phase peptide synthesis SPPS method is the most commonly and widely used method for peptide synthesis. In this method, first amino acid is anchored to a solid support, which is usually a resin, and building the peptide chain sequentially by adding protected amino acids which is also a part of solid-phase peptide synthesis. The solid phase peptide synthesis involves five steps: activation, coupling, deprotection, repeated coupling and deprotection, final deprotection and cleavage.
- LPPS is an alternative method that involves solution-phase reactions. It is typically used for synthesizing smaller peptides or peptide fragments. LPPS requires protecting groups to selectively react with specific amino acids and prevent unwanted reactions. In LPPS, the amino acids are activated and sequentially coupled in solution. After each coupling step, the protecting groups are selectively removed, and the process is repeated until the desired peptide sequence is achieved. The final peptide is purified by techniques such as chromatography or crystallization.
Global Peptide Synthesis Market Analysis
The market for peptide synthesis is influenced by several trends, including the increased emphasis on peptide libraries and screening. The rising demand for long and difficult peptides is growing, including cyclic peptides, stapled peptides, and peptide conjugates. These peptides offer unique properties and enhanced stability, making them attractive for drug development and research applications.
Additionally, peptide-based therapeutics are continuously being explored for the treatment of rare genetic diseases as targeting specific peptides can potentially correct or modulate genetic defects. The development of peptide therapies for rare diseases is gaining momentum, which is driven by the advancements in gene editing technologies and personalized medicine approaches. Researchers are increasingly incorporating non-natural amino acids into peptide sequences to enhance their stability, bioactivity, and pharmacokinetic properties. This allows the development of peptide-based therapeutics with improved drug-like characteristics, expanding the potential applications of peptides in drug discovery and delivery. Outsourcing peptide synthesis to contract manufacturing organizations (CMOs) is becoming a popular trend among pharmaceutical and biotech companies, which is leading to higher peptide synthesis market demand. This trend allows companies to focus on their core competencies while accessing high-quality peptides for their drug development pipelines.
Automation and robotics are also being increasingly employed in peptide synthesis processes that enables high-throughput and efficient production. Automated peptide synthesizers and robotic systems facilitate precise control, rapid synthesis, and reduced human error, thereby enhancing the scalability and reproducibility of peptide manufacturing.
Global Peptide Synthesis Market Segmentations
Peptide Synthesis Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Technology
- Solid-Phase
- Liquid-Phase
- Hybrid
- Recombinant
- Equipment
- Reagents
- Consumables
- Other Product
- Pharmaceutical and Biotechnology Companies
- Contract Development and Manufacturing Organization (CDMO)
- Academic and Research Institutes
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The market for peptide synthesis has been witnessing steady growth and is anticipated to witness significant growth in the coming years as well. The market growth is primarily driven by the increasing demand for therapeutics. Due to their exclusivity, potency, and low toxicity in comparison to traditional small molecule drugs, the demand for peptide-based therapeutics in regard with various diseases, such as cancer, diabetes, and cardiovascular disorders, is increasing and directly contributing to the global peptide synthesis market growth.
Additionally, the increasing number of ongoing advancements in peptide research, including understanding the structure-activity relationships and developing new synthesis techniques, are collectively contributing to the possibilities for the introduction of peptide-based therapeutics in the market with multiple benefits, propelling the demand for peptide synthesis technologies and services in the market.
The increasing emphasis on personalized medicine and targeted therapies has increased the demand for customized peptides in the market. Peptide synthesis enables the creation of peptides with unique sequences and modifications tailored to individual patient needs, leading to the development of personalized treatments. The rising availability of customisation as per the requirement is also contributing to the peptide synthesis market share. Peptides find applications in various fields, including biotechnology, life sciences, and diagnostics. Peptides are also used as tools for comprehending protein-protein interactions, as diagnostic biomarkers, and in the development of peptide-based vaccines. The expanding applications of peptides across these industries aid the growth of the peptide synthesis market.
Peptide Synthesis Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- AAPPTec
- Anaspec
- Bachem Holding AG
- Biotage
- CSBio Company Inc.
- CEM Corporation
- Gyros Protein Technologies AB
- Merck KGaA
- Biosynth Carbosynth (Vivitide)
- Thermo Fisher Scientific
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Peptide Synthesis Market Overview
- 3.1 Global Peptide Synthesis Market Historical Value (2018-2024)
- 3.2 Global Peptide Synthesis Market Forecast Value (2025-2034)
- 4 Global Peptide Synthesis Market Landscape
- 4.1 Global Enteric Disease Testing: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Enteric Disease Testing: Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Applications
- 5 Global Peptide Synthesis Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Peptide Synthesis Market Segmentation
- 6.1 Global Peptide Synthesis Market by Technology
- 6.1.1 Solid-Phase
- 6.1.2 Liquid-Phase
- 6.1.3 Hybrid
- 6.1.4 Recombinant
- 6.2 Global Peptide Synthesis Market by Products
- 6.2.1 Market Overview
- 6.2.2 Equipment
- 6.2.3 Reagents
- 6.2.4 Consumables
- 6.2.5 Other Product
- 6.3 Global Peptide Synthesis Market by End User
- 6.3.1 Market Overview
- 6.3.2 Pharmaceutical and Biotechnology Companies
- 6.3.3 Contract Development and Manufacturing Organization (CDMO)
- 6.3.4 Academic and Research Institutes
- 6.4 Global Peptide Synthesis Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Peptide Synthesis Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Peptide Synthesis Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Peptide Synthesis Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Peptide Synthesis Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Peptide Synthesis Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Clinical Trials Analysis
- 15.1 Analysis by Trial Registration Year
- 15.2 Analysis by Trial Status
- 15.3 Analysis by Trial Phase
- 15.4 Analysis by Therapeutic Area
- 15.5 Analysis by Geography
- 16 Funding and Investment Analysis
- 16.1 Analysis by Funding Instances
- 16.2 Analysis by Type of Funding
- 16.3 Analysis by Funding Amount
- 16.4 Analysis by Leading Players
- 16.5 Analysis by Leading Investors
- 16.6 Analysis by Geography
- 17 Partnership and Collaborations Analysis
- 17.1 Analysis by Partnership Instances
- 17.2 Analysis by Type of Partnership
- 17.3 Analysis by Leading Players
- 17.4 Analysis by Geography
- 18 Supplier Landscape
- 18.1 AAPPTec
- 18.1.1 Financial Analysis
- 18.1.2 Product Portfolio
- 18.1.3 Demographic Reach and Achievements
- 18.1.4 Mergers and Acquisitions
- 18.1.5 Certifications
- 18.2 Anaspec
- 18.2.1 Financial Analysis
- 18.2.2 Product Portfolio
- 18.2.3 Demographic Reach and Achievements
- 18.2.4 Mergers and Acquisitions
- 18.2.5 Certifications
- 18.3 Bachem Holding AG
- 18.3.1 Financial Analysis
- 18.3.2 Product Portfolio
- 18.3.3 Demographic Reach and Achievements
- 18.3.4 Mergers and Acquisitions
- 18.3.5 Certifications
- 18.4 Biotage
- 18.4.1 Financial Analysis
- 18.4.2 Product Portfolio
- 18.4.3 Demographic Reach and Achievements
- 18.4.4 Mergers and Acquisitions
- 18.4.5 Certifications
- 18.5 CSBio Company Inc.
- 18.5.1 Financial Analysis
- 18.5.2 Product Portfolio
- 18.5.3 Demographic Reach and Achievements
- 18.5.4 Mergers and Acquisitions
- 18.5.5 Certifications
- 18.6 CEM Corporation
- 18.6.1 Financial Analysis
- 18.6.2 Product Portfolio
- 18.6.3 Demographic Reach and Achievements
- 18.6.4 Mergers and Acquisitions
- 18.6.5 Certifications
- 18.7 Gyros Protein Technologies AB
- 18.7.1 Financial Analysis
- 18.7.2 Product Portfolio
- 18.7.3 Demographic Reach and Achievements
- 18.7.4 Mergers and Acquisitions
- 18.7.5 Certifications
- 18.8 Merck KGaA
- 18.8.1 Financial Analysis
- 18.8.2 Product Portfolio
- 18.8.3 Demographic Reach and Achievements
- 18.8.4 Mergers and Acquisitions
- 18.8.5 Certifications
- 18.9 Biosynth Carbosynth (Vivitide)
- 18.9.1 Financial Analysis
- 18.9.2 Product Portfolio
- 18.9.3 Demographic Reach and Achievements
- 18.9.4 Mergers and Acquisitions
- 18.9.5 Certifications
- 18.10 Thermo Fisher Scientific
- 18.10.1 Financial Analysis
- 18.10.2 Product Portfolio
- 18.10.3 Demographic Reach and Achievements
- 18.10.4 Mergers and Acquisitions
- 18.10.5 Certifications
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

